MUTATIONS CLUSTERED IN EXON-5 OF THE P53 GENE IN PRIMARY NASOPHARYNGEAL CARCINOMAS FROM SOUTHEASTERN ASIA

被引:23
作者
CHAKRANI, F
ARMAND, JP
LENOIR, G
JU, LY
LIANG, JP
MAY, E
MAY, P
机构
[1] CNRS,IFR,IRC,MOLEC ONCOL LAB,F-94801 VILLEJUIF,FRANCE
[2] INST BIOMED CORDELIERS,IMMUNOGENET MOLEC LAB,F-75006 PARIS,FRANCE
[3] CTR INT RECH CANC,LYON,FRANCE
[4] GUANGXI AUTONOM REG HOSP,GUANGXI,PEOPLES R CHINA
[5] INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE
关键词
D O I
10.1002/ijc.2910610307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in the p53 tumor suppressor gene play an important role in the development of many common human malignancies. In nasopharyngeal carcinomas (NPC), p53 gene mutations were not detected in primary tumors, with one exception for a primary tumor displaying a p53 mutation at codon 280, whereas p53 mutations were identified in some metastatic and nude mouse-passaged NPC specimens. In the present report, 41 NPC primary tumors of the undifferentiated carcinoma nasopharyngeal type (UCNT; 21 from Hong Kong and 20 from Guangxi, southeastern China) were studied. Four point mutations that result in amino acid substitutions were identified by PCR amplification of exons 2-9 and direct DNA sequencing, combined with PCR-single-strand conformation polymorphism analysis. The 4 mutations detected were clustered within the DNA stretch from codon 175 to 177. Our data, taken together with those of others, suggest that mutation in p53 may occur in NPC at various points during tumorigenesis. Alternative mechanisms of p53 inactivation in NPC are also possible. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:316 / 320
页数:5
相关论文
共 21 条
[1]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[2]   GENETIC MECHANISMS OF TUMOR SUPPRESSION BY THE HUMAN P53 GENE [J].
CHEN, PL ;
CHEN, YM ;
BOOKSTEIN, R ;
LEE, WH .
SCIENCE, 1990, 250 (4987) :1576-1580
[3]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[4]   NASOPHARYNGEAL CARCINOMA - BIOLOGY, NATURAL-HISTORY, AND THERAPEUTIC IMPLICATIONS [J].
CVITKOVIC, E ;
BACHOUCHI, M ;
ARMAND, JP .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (04) :821-838
[5]   ALTERATIONS OF THE P53 GENE IN NASOPHARYNGEAL CARCINOMA [J].
EFFERT, P ;
MCCOY, R ;
ABDELHAMID, M ;
FLYNN, K ;
ZHANG, Q ;
BUSSON, P ;
TURSZ, T ;
LIU, E ;
RAABTRAUB, N .
JOURNAL OF VIROLOGY, 1992, 66 (06) :3768-3775
[6]   WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
ELIYAHU, S ;
PINHASIKIMHI, O ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8763-8767
[7]   THE MDM-2 ONCOGENE CAN OVERCOME WILD-TYPE P53 SUPPRESSION OF TRANSFORMED-CELL GROWTH [J].
FINLAY, CA .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) :301-306
[8]  
GREENBLATT MS, 1994, CANCER RES, V54, P4855
[9]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[10]  
LEVINE AJ, 1990, NATURE, V351, P453